Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
Barriers to CNS infections
|
1. Anatomical- Bones and membranes protect CNS from external environment. Bones and membranes create limited space – effects of infections magnified
2. Physiological- Blood-brain barrier prevents entry of microbes and toxic substances into CSF. Blood-brain barrier prevents passage of antibodies, cytotoxic cells and antimicrobial drugs into CNS |
|
Classification of CNS infections
|
1. Encephalitis – infection of brain parenchyma
2. Meningitis – infection of meninges 3. Myelitis – infection of spinal cord tissue 4. Neuritis – infection of peripheral nerves |
|
Microbial entry to CNS
|
1. Microbes usually start in peripheral tissues then move to CNS hematogenously- Nasopharynx, GI tract
2. Enter via direct inoculation – trauma 3. Enter via neural pathways- HSV, rabies 4. Some viruses remain sequestered in CNS in a latent state- HSV, varicella-zoster |
|
Defenses in CNS
|
1. Antibodies uncommon- Complement levels low
2. Specialized phagocytes – microglia- Phagocytosis hampered by low levels of complement and antibodies to opsonize microorganisms |
|
Tissue damage in CNS infections is caused by?
|
Bacterial toxins, Viral lytic cycles, Intracellular growth of bacteria and fungi,Most damage from host’s inflammatory response
|
|
Host response to CNS infection
|
1. Viruses and intracellular bacteria – “aseptic meningitis”
Increase in lymphocytes and monocytes Slight increase in protein levels Glucose levels constant 2. Extracellular bacteria – “septic meningitis” Increased levels of neutrophils Protein levels increase significantly Glucose levels decrease |
|
Enterovirus (picornavirus family)- Polio virus infection
|
1. Nonenveloped
2. ssRNA(+) sense genome 3. Nonsegmented genome-Encodes polyprotein – cleaved into enzymes and structural proteins and Protease degrades cap-binding protein of host mRNA 4. 5’-untranslated leader sequence on RNA |
|
Salk polio vaccine (IPV)
|
1. Introduced 4-12-55- Killed virus vaccine- Contains serotypes 1, 2, and 3
2. Injected; boosters required- Elicits only IgG and IgM 3. Currently used in U.S. |
|
Sabin polio vaccine (OPV)
|
1. Attenuated live vaccine given orally-Contains serotypes 1, 2, and 3
2. Replicates well in GI tract but not in neural tissue- Elicits synthesis of IgA 3. May occasionally revert 4. Not used in U.S. |
|
Bacterial meningitis
|
Bacteria colonize and invade mucosa
|
|
Bacterial meningitis virulence factors
|
1. IgA proteases, Prevention of ciliary action and Attachment structures that include: Adhesins, Pili and Capsules
2. Mechanisms for crossing mucosa to bloodstream: Endocytosis and Damage to tight junctions 3. Capsules provide protection in bloodstream |
|
How does Bacterial meningitis cross the BBB
|
1. Bacteria attach to blood vessels
2. Damage to endothelial cells causes inflammation 3. Endothelial lining of vessels becomes “leaky” 4. Some species travel in monocytes |
|
Neonatal meningitis- what are the 2 main causes?
|
Group B streptococci and E. coli K-1
|
|
Group B streptococci- Neonatal meningitis
|
1. Main cause of neonatal meningitis- Gram(+) cocci
2. 5 different capsular serotypes 3. No vaccine |
|
E. coli K-10- cause of neonatal meningitis
|
1. Second most common cause- Part of resident biota
2. Gram (-) rods 3. Capsule – sialic acid: Serum resistance and Antiphagocytic 4. No vaccine |
|
Streptococcus pneumoniae
|
1. Common cause of meningitis in adults. Moves from lungs or sinuses to bloodstream
2. Polysaccharide capsule- Used for 2 vaccines |
|
Haemophilus influenzae type b
|
1. Previously most common cause of meningitis in children between 3 months and 5 years
2. Antiphagocytic polysaccharide capsule 3. Effective vaccine – conjugate vaccine |
|
Neisseria meningitidis
|
1. Colonizes throat or nasopharynx - asymptomatic
2. Causes brain lesions |
|
Cryptococcus neoformans
|
Causes brain lesions
|
|
Diagnosis of meningitis
|
1. CSF samples: Look for immune cells, Determine glucose level, Diagnostic kits for bacterial and fungal antigens
2. Blood samples are cultivated |
|
African sleeping sickness
|
1. Caused by Trypanosoma brucei
2. Uniformly fatal within two years 3. Vaccine prospects poor due to antigenic variation 4. Drugs toxic, only effective in early stages 5. Carrier is the Tsete fly and trypomastigote is the is the infectious agent 6. Chronic disease: Causing Meningitis, Convulsions, Coma and Death 7. To control it must eliminate tsetse flies and block access of flies to humans in endemic areas |